Article

Thyroid dysfunction after immune checkpoint inhibitor treatment in a single-center Chinese cohort: a retrospective study

2022-11-09

Abstract excerpt

<title>Abstract</title> <p>Background Thyroid dysfunction is a common adverse event after immune checkpoint inhibitor (ICI) therapy. The clinical manifestations of thyroid immune-related adverse events (irAEs) are variable and the underlying mechanism is unclear. Purpose To identify the clinical and biochemical characteristics of Chinese patients with ICI-related thyroid dysfunction. Methods We retrospectively...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: dd10243b-da97-57c2-9c14-31a579e96bc6
DOI: 10.21203/rs.3.rs-2210602/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Thyroid dysfunction after immune checkpoint inhibitor treatment in a single-center Chinese cohort: a retrospective studyDOI 10.21203/rs.3.rs-2210602/v1Read

Immune Checkpoint Inhibitors-Related Thyroid Dysfunction: Epidemiology, Clinical Presentation, Possible Pathogenesis, and Management.Semantic proximity Read

Transcriptomic signatures associated with autoimmune thyroiditis in papillary thyroid carcinoma and cancer immunotherapy-induced thyroid dysfunctionSemantic proximity Read

Clonally-Expanded, Thyrotoxic Autoimmune Mediator CD8 <sup>+</sup> T cells Driven by IL21 Contribute to Checkpoint Inhibitor ThyroiditisSemantic proximity Read

Research progress on mechanisms and predictive biomarkers for immune-related adverse eventsSemantic proximity Read

Novel targeted therapies and immunotherapy for advanced thyroid cancers.Semantic proximity Read

Thyroid cancer and thyroid autoimmune disease: A review of molecular aspects and clinical outcomes.Semantic proximity Read

Pan‐cancer analysis identifies TERT alterations as predictive biomarkers for immune checkpoint inhibitors treatmentSemantic proximity Read

Insights Into the Host Contribution of Endocrine Associated Immune-Related Adverse Events to Immune Checkpoint Inhibition TherapySemantic proximity Read

Inhibition of the IL-17A axis Protects against Immune-related Adverse Events while Supporting Checkpoint Inhibitor Anti-tumor EfficacySemantic proximity Read

T cell exhaustion is associated with the risk of papillary thyroid carcinoma and can be a predictive and sensitive biomarker for diagnosis.Semantic proximity Read

Risk of second primary malignancy after radioiodine for thyroid carcinoma: a SEER-based studySemantic proximity Read